tiprankstipranks
Blurbs

Analysts’ Top Consumer Goods Picks: Five Below (FIVE), Celsius Holdings (CELH)

There’s a lot to be optimistic about in the Consumer Goods sector as 3 analysts just weighed in on Five Below (FIVEResearch Report), Celsius Holdings (CELHResearch Report) and CVS Health (CVSResearch Report) with bullish sentiments.

Five Below (FIVE)

In a report released today, Bradley Thomas from KeyBanc maintained a Buy rating on Five Below, with a price target of $190.00. The company’s shares closed last Friday at $138.56.

According to TipRanks.com, Thomas is a 5-star analyst with an average return of 11.9% and a 58.9% success rate. Thomas covers the Consumer Goods sector, focusing on stocks such as Ollie’s Bargain Outlet Holding, Bed Bath & Beyond, and Tempur Sealy.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Five Below with a $166.79 average price target, implying a 23.4% upside from current levels. In a report issued on July 25, J.P. Morgan also maintained a Buy rating on the stock with a $165.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Celsius Holdings (CELH)

Jefferies analyst Kevin Grundy maintained a Buy rating on Celsius Holdings yesterday and set a price target of $125.00. The company’s shares closed last Friday at $98.62, close to its 52-week high of $110.22.

According to TipRanks.com, Grundy is a 4-star analyst with an average return of 5.1% and a 62.8% success rate. Grundy covers the Consumer Goods sector, focusing on stocks such as Constellation Brands, Energizer Holdings, and Duckhorn Portfolio.

Celsius Holdings has an analyst consensus of Strong Buy, with a price target consensus of $102.63, implying a -0.8% downside from current levels. In a report issued on August 2, B.Riley Financial also maintained a Buy rating on the stock with a $112.00 price target.

CVS Health (CVS)

Credit Suisse analyst Jonathan Yong maintained a Buy rating on CVS Health today and set a price target of $117.00. The company’s shares closed last Friday at $102.26.

According to TipRanks.com, Yong is ranked #6326 out of 7991 analysts.

Currently, the analyst consensus on CVS Health is a Moderate Buy with an average price target of $118.92, representing a 17.2% upside. In a report issued on August 3, J.P. Morgan also maintained a Buy rating on the stock with a $130.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on FIVE:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More